Summary
Updated Aug 30, 2026
Richard M. Glickman files SEC Form 4 reports at enGene Therapeutics Inc. (ENGN). 2 SEC Form 4 filings on record going back to 2025, most recently on 17 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Richard M. Glickman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Richard M. Glickman. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Forbion Growth Opportunities Fund I Cooperatief U.A. - $8.01M of ENGN open-market activity on record
- Ronald Harold Wilfred Cooper - $57K of ENGN open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Richard M. Glickman?
Richard M. Glickman is a corporate insider of enGene Therapeutics Inc. (ENGN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard M. Glickman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Richard M. Glickman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Richard M. Glickman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
